Value Communications and Strategy

Optimizing market access through enhanced evidence-based value communications

 

Expertise includes:

  • Global value dossiers (GVDs), AMCP dossiers, value messages, value stories and propositions, payer value narratives (PVNs), core value slide decks, payer/KOL engagement slide decks, objection handlers
  • Stakeholder engagement support, including discussion guides for payer and KOL interviews
  • Evidence gap analyses and treatment, payer, competitor landscape assessments to inform strategy
  • Identification and communication of evidence-based product differentiators to support product value and strengthen market access strategy
  • Review and refinement of existing materials to ensure clear, compelling narratives aligned with strategic communication goals
  • Can identify and leverage a broad spectum of research evidence to build a robust foundation that can support and underscore the value proposition of a pharmaceutical product or medical device
  • Development of educational materials for country-level market access teams
  • End-to-end GVD/PVN support, from literature searches and clinical, economic, and real-world evidence evaluation to value message development and testing, and dossier writing

Select examples of completed projects

 

Deliverables Therapy areas
GVDs/AMCP dossiers  Oncology (solid and haematologic malignancies), immunology, haematology, neurology, nephrology, gastroenterology, respiratory, cardiology, rare and ultra-rare diseases  
HTA submission documentation Oncology (solid and haematologic malignancies), haematology, respiratory, rare diseases
Value strategy 

Oncology (solid and haematologic malignancies), cardiovascular, rheumatology, nephrology, rare diseases

Print | Sitemap
© 2025 Lorena Tonarelli, M.Sc., B.Sc. (Hons)⎜Lorena Tonarelli MSc is a trading name of LT Medical & Value Communications Ltd, registered in England and Wales ⎜Company No 12274369.